BEGIN:VCALENDAR VERSION:2.0 PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4// BEGIN:VEVENT UID:20250312T180243EDT-9940uFihUa@132.216.98.100 DTSTAMP:20250312T220243Z DESCRIPTION:The Centre for Intellectual Property Policy welcomes Professor Jacob S. Sherkow\, New York Law School.\n\nAbstract\n\nCRISPR is a revolut ionary advance in biotechnology: it allows molecular biologists to edit ce lls’ DNA with ease and precision unimaginable even a decade ago. The techn ology is also the subject of contentious patent dispute between several un iversities\, and governed by a maze of licensing agreements among research institutions\, nonprofits\, biotech startups\, and large pharmaceutical d evelopers.\n\nPatents in the CRISPR space illuminate numerous problems—and advantages—of university-based intellectual property for groundbreaking t echnologies. The CRISPR patents herald the beginning of skepticism over in terinstitutional collaboration\, especially for lucrative “translational” technologies. And they have encouraged universities—otherwise committed to licensing their patents widely—to invest in for-profit surrogate companie s to narrowly manage their license agreements for them. At the same time\, CRISPR patents have allowed publicly minded research institutions to reta in control over the technology to essentially prevent some of the technolo gy’s greatest potential abuses: runaway genetic modifications in the wild\ , also known as “gene drives”\; seed-saving restrictions for agriculture\; and germ-line human engineering.\n\nUsing four short papers as guides\, t his talk will present an overview of these issues and discuss their applic ation to future applications of CRISPR and other significant university-de veloped technology.\n\nSpeaker\n\nJacob S. Sherkow is an Associate Profess or of Law and affiliated faculty at the Innovation Center for Law and Tech nology at New York Law School\, where he teaches a variety of courses rela ted to intellectual property. His research focuses on how scientific devel opments\, especially in the biosciences\, affect patent law and litigation . Prof. Sherkow is the author of over two dozen articles on these and rela ted topics in both traditional law reviews and scientific journals\, inclu ding the Yale Law Journal\, the Stanford Law Review\, Science\, and Nature . He has been a frequent commentator on patent matters in popular outlets such as the Wall Street Journal\, The New York Times\, the Los Angeles Tim es\, and NPR.\n\nProf. Sherkow also currently serves as a community repres entative on the New York Genome Center’s Institutional Biosafety Committee \, and has advised a committee of France’s National Assembly on issues con cerning the patenting of biotechnological research tools. Previously\, Pro f. Sherkow was a Fellow in the Center for Law and the Biosciences at Stanf ord Law School and a patent litigator at Gibson\, Dunn & Crutcher in New Y ork. He was also a law clerk in the U.S. District Court for the Eastern Di strict of New York.\n Prof. Sherkow graduated cum laude from the University of Michigan Law School\, where he was an editor of the Michigan Law Revie w and was the recipient of the Fred L. Leckie and James N. Adler Scholarsh ips. He also holds an M.A. in biotechnology from Columbia University and a B.Sc. from ϲ University\, where he majored in molecular biology and English literature. In addition to his legal training\, Prof. Sherkow has several years of experience as a research scientist in molecular biology\, is a certified Editor in the Life Sciences (BELS)\, and is an avid squash player.\n DTSTART:20170324T170000Z DTEND:20170324T183000Z LOCATION:NCDH 316\, Chancellor Day Hall\, CA\, QC\, Montreal\, H3A 1W9\, 36 44 rue Peel SUMMARY:University Patent Licenses in the CRISPR Era URL:/channels/event/university-patent-licenses-crispr- era-266449 END:VEVENT END:VCALENDAR